A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
Clinical trial NCT06110793 · RECRUITING
Trial details
- NCT number
- NCT06110793
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-29
- Primary completion
- 2027-11-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.